Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Return on Equity (2022 - 2025)

Historic Return on Equity for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to 0.76%.

  • Pulse Biosciences' Return on Equity rose 1100.0% to 0.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.67% for FY2024, which is 13300.0% up from last year.
  • As of Q3 2025, Pulse Biosciences' Return on Equity stood at 0.76%, which was up 1100.0% from 0.61% recorded in Q2 2025.
  • In the past 5 years, Pulse Biosciences' Return on Equity registered a high of 7.9% during Q1 2023, and its lowest value of 29.69% during Q4 2022.
  • In the last 5 years, Pulse Biosciences' Return on Equity had a median value of 0.87% in 2024 and averaged 2.38%.
  • In the last 5 years, Pulse Biosciences' Return on Equity plummeted by -290400bps in 2022 and then surged by 288200bps in 2023.
  • Over the past 5 years, Pulse Biosciences' Return on Equity (Quarter) stood at 0.65% in 2021, then plummeted by -4486bps to 29.69% in 2022, then skyrocketed by 97bps to 0.87% in 2023, then soared by 37bps to 0.55% in 2024, then crashed by -37bps to 0.76% in 2025.
  • Its Return on Equity stands at 0.76% for Q3 2025, versus 0.61% for Q2 2025 and 0.52% for Q1 2025.